Annamycin

3 trials 1 recruiting LOncology Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

2 Sponsors

9 Countries

Phase II/III

Phase I/II

Phase II/III: 1 Phase I/II: 2

Sponsors using this IMP

Moleculin Biotech Inc. 2 Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy 1

All trials

3 total

A phase 2/3, multi-center, study of L-Annamycin in combination with cytarabine vs. placebo in combination with cytarabine as second line the… Recruiting

2024-518359-47-00 Phase II/III 9 countries Moleculin Biotech Inc.
A clinical study conducted to evaluate the safety, efficacy and tolerability of a drug called liposomal annamycin administered with cytarabi… Ended

2024-516388-10-00 Phase I/II 2 countries Moleculin Biotech Inc.
Phase 1b/2 study of liposomal annamycin (l-annamycin) in patients with previously treated metastatic soft-tissue sarcomas (ANNA-SARC) Ended

2024-517678-12-00 Phase I/II 1 country Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Bada…

Showing 1–3 of 3 trials

← All drugs A–Z